FR2476087A1
(en)
|
1980-02-18 |
1981-08-21 |
Roussel Uclaf |
NOVEL OXIMES DERIVED FROM 3-ALKYLOXY OR 3-ALKYL-THIOMETHYL 7-AMINO THIAZOLYL ACETAMIDO CEPHALOSPORANIC ACID, PROCESS FOR PREPARING THEM AND THEIR APPLICATION AS MEDICAMENTS
|
GB9108279D0
(en)
|
1991-04-18 |
1991-06-05 |
Ucb Sa |
A method of preparing 1h-benzimidazoles
|
CN100358883C
(en)
|
1998-06-02 |
2008-01-02 |
中国科学院上海有机化学研究所 |
Five-membered aromatic heterocyclic compounds contg. beta-position trifluoromethyl group and synthesis thereof
|
FR2792316B1
(en)
|
1999-04-13 |
2001-06-22 |
Synthelabo |
1-AMINOETHYLINDOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
|
US7439359B2
(en)
|
2000-11-02 |
2008-10-21 |
Sloan-Kettering Institute For Cancer Research |
Small molecule compositions for binding to hsp90
|
US20070129334A1
(en)
|
2001-10-30 |
2007-06-07 |
Conforma Therapeutics Corporation |
Orally Active Purine-Based Inhibitors of Heat Shock Protein 90
|
AU2002356922A1
(en)
|
2001-11-09 |
2003-05-26 |
Conforma Therapeutics Corporation |
Hsp90-inhibiting zearalanol compounds and methods of producing and using same
|
EP1521625B1
(en)
|
2002-07-11 |
2009-03-11 |
GEA BGR Energy System India Ltd. |
A debris filter with a rotating debris extractor
|
US7037522B2
(en)
|
2002-09-27 |
2006-05-02 |
Western Holdings, L.L.C. |
Nocturnal muscle enhancing composition and method
|
GB0228417D0
(en)
|
2002-12-05 |
2003-01-08 |
Cancer Rec Tech Ltd |
Pyrazole compounds
|
GB0229618D0
(en)
|
2002-12-19 |
2003-01-22 |
Cancer Rec Tech Ltd |
Pyrazole compounds
|
WO2004072081A1
(en)
|
2003-02-10 |
2004-08-26 |
Cellular Genomics, Inc. |
Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity
|
GB0309637D0
(en)
|
2003-04-28 |
2003-06-04 |
Cancer Rec Tech Ltd |
Pyrazole compounds
|
WO2005009345A2
(en)
|
2003-06-13 |
2005-02-03 |
Kosan Biosciences, Inc. |
2-desmethyl ansamycin compounds
|
US7538224B2
(en)
|
2003-06-27 |
2009-05-26 |
Kyowa Hakko Kogyo Co., Ltd. |
Hsp90 family protein inhibitors
|
GB0315111D0
(en)
|
2003-06-27 |
2003-07-30 |
Cancer Rec Tech Ltd |
Substituted 5-membered ring compounds and their use
|
GB0315657D0
(en)
|
2003-07-03 |
2003-08-13 |
Astex Technology Ltd |
Pharmaceutical compounds
|
AU2004200774A1
(en)
|
2003-07-07 |
2005-01-27 |
Holyrood Exports Pty Ltd |
Padlock Protector
|
KR20060030510A
(en)
|
2003-07-11 |
2006-04-10 |
코니카 미놀타 옵토 인코포레이티드 |
Optical pickup device, optical element used for optical pickup device, and method for producing optical element
|
AU2004268820B2
(en)
|
2003-08-29 |
2011-07-21 |
Cancer Research Technology Ltd |
Pyrimidothiophene compounds
|
US6855705B1
(en)
|
2003-11-12 |
2005-02-15 |
Kosan Biosciences, Inc. |
11-O-methylgeldanamycin compounds
|
DE10354133A1
(en)
|
2003-11-19 |
2005-06-23 |
Phoenix Ag |
conveyor belt
|
AU2004309395C1
(en)
|
2003-12-23 |
2012-10-04 |
Infinity Discovery, Inc. |
Analogs of benzoquinone-containing ansamycins for the treatment of cancer
|
US20060019941A1
(en)
|
2003-12-23 |
2006-01-26 |
Infinity Pharmaceuticals, Inc. |
Analogs of benzoquinone-containing ansamycins and methods of use thereof
|
US7491701B2
(en)
|
2004-01-27 |
2009-02-17 |
Boys Town National Research Hospital |
Peptides that bind to HSP90 proteins
|
JP2005225787A
(en)
|
2004-02-12 |
2005-08-25 |
Nippon Kayaku Co Ltd |
Hsp90 inhibitor
|
JP4254633B2
(en)
|
2004-06-28 |
2009-04-15 |
株式会社イトーキ |
Rotation control device for swivel chair
|
GB0416168D0
(en)
|
2004-07-20 |
2004-08-18 |
Vernalis Cambridge Ltd |
Pyrmidothiophene compounds
|
US7342093B2
(en)
|
2004-07-23 |
2008-03-11 |
University Of Massachusetts |
Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins
|
PE20060572A1
(en)
|
2004-07-27 |
2006-06-27 |
Novartis Ag |
BENZOIMIDAZOLONE COMPOUNDS AS HSP90 INHIBITORS
|
JP2008508218A
(en)
|
2004-07-27 |
2008-03-21 |
ノバルティス アクチエンゲゼルシャフト |
HSP90 inhibitor
|
KR101045324B1
(en)
|
2004-08-11 |
2011-06-30 |
한국생명공학연구원 |
Geldanamycin derivatives and the method for biosynthesis thereof
|
DE102004039280A1
(en)
|
2004-08-13 |
2006-02-23 |
Merck Patent Gmbh |
1,5-diphenyl-pyrazoles
|
US7208630B2
(en)
|
2004-10-27 |
2007-04-24 |
University Of Kansas |
Heat shock protein 90 inhibitors
|
WO2006050477A2
(en)
|
2004-11-03 |
2006-05-11 |
K2 Concepts |
Anti-microbial compositions and methods of making and using the same
|
US7608594B2
(en)
|
2004-11-03 |
2009-10-27 |
University Of Kansas |
Novobiocin analogues as anticancer agents
|
US7622451B2
(en)
|
2004-11-03 |
2009-11-24 |
University Of Kansas |
Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
|
CN101072759B
(en)
|
2004-11-18 |
2013-06-19 |
Synta医药公司 |
Triazole compounds that modulate HSP90 activity
|
FR2880540B1
(en)
|
2005-01-13 |
2008-07-11 |
Aventis Pharma Sa |
USE OF PURINE DERIVATIVES AS INHIBITORS OF HSP90 PROTEIN
|
GB0501535D0
(en)
|
2005-01-25 |
2005-03-02 |
Vernalis R&D Ltd |
Pyrimidothiophene compounds
|
WO2006084030A2
(en)
|
2005-02-01 |
2006-08-10 |
Sloan-Kettering Institute For Cancer Research |
Small-molecule hsp90 inhibitors
|
DE102005007304A1
(en)
|
2005-02-17 |
2006-08-24 |
Merck Patent Gmbh |
triazole derivatives
|
FR2882361A1
(en)
|
2005-02-22 |
2006-08-25 |
Aventis Pharma Sa |
New 3-aryl-1,2-benzisoxazole compounds are heat shock protein 90 inhibitors, useful to treat solid or liquid cancer, preferably cancers resistant to cytotoxic agents
|
KR20150029766A
(en)
|
2005-02-25 |
2015-03-18 |
에사넥스, 인코포레이티드 |
Tetrahydroindolone and tetrahydroindazolone derivatives
|
WO2006090094A1
(en)
|
2005-02-28 |
2006-08-31 |
Vernalis R & D Ltd |
Pyrimidothiophene compounds for use as hsp90 inhibitors
|
RU2007137133A
(en)
|
2005-03-09 |
2009-04-20 |
Ниппон Каяку Кабусики Кайся (Jp) |
NEW HSP90 INHIBITOR
|
EP1863769A4
(en)
|
2005-03-11 |
2009-03-18 |
Univ Colorado |
Hsp90 inhibitors, methods of making and uses therefor
|
WO2006100907A1
(en)
|
2005-03-22 |
2006-09-28 |
Matsushita Electric Industrial Co., Ltd. |
Imaging device and mobile radio communication terminal
|
JP2008137894A
(en)
|
2005-03-22 |
2008-06-19 |
Nippon Kayaku Co Ltd |
New acetylene derivative
|
KR20080004550A
(en)
|
2005-03-30 |
2008-01-09 |
콘포마 세러퓨틱스 코포레이션 |
Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors
|
FR2884252B1
(en)
|
2005-04-08 |
2007-05-18 |
Aventis Pharma Sa |
NOVEL ISOINDOLE DERIVATIVES, COMPOSITIONS CONTAINING SAME, PREPARATION THEREOF AND PHARMACEUTICAL USES THEREOF, IN PARTICULAR AS INHIBITORS OF CHAPERONE HSP90 PROTEIN ACTIVITY
|
CA2604042C
(en)
|
2005-04-13 |
2016-06-21 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
CN101198596A
(en)
|
2005-04-14 |
2008-06-11 |
诺华疫苗和诊断公司 |
2-amino-quinaz0lin-5-ones as HSP90 inhibitors useful in treating proliferation diseases
|
JP2008540395A
(en)
|
2005-05-03 |
2008-11-20 |
ファイザー・インク |
Amidoresorcinol compounds
|
DE102005022977A1
(en)
|
2005-05-19 |
2006-12-07 |
Merck Patent Gmbh |
Phenylchinazolinderivate
|
FR2885904B1
(en)
|
2005-05-19 |
2007-07-06 |
Aventis Pharma Sa |
NOVEL FLUORENE DERIVATIVES, COMPOSITIONS CONTAINING SAME AND USE THEREOF
|
FR2886038B1
(en)
|
2005-05-20 |
2008-02-01 |
Fasver Sa Sa |
ANTI-FALSIFY FLEXIBLE SAFETY ADHESIVE VIGNETTE, OFFICIAL DOCUMENT COMPRISING SUCH A THUMBNAIL AND A METHOD OF MANUFACTURING THE SAME
|
AU2006251169A1
(en)
|
2005-05-25 |
2006-11-30 |
4Sc Ag |
Tetrahydropyridothiophenes for use in the treatment of cancer
|
CA2609003A1
(en)
|
2005-05-25 |
2006-11-30 |
Nycomed Gmbh |
Tetrahydropyridothiophenes for use in the treatment of cancer
|
DE102005024245A1
(en)
|
2005-05-27 |
2006-11-30 |
Merck Patent Gmbh |
thienopyridines
|
WO2007001966A2
(en)
|
2005-06-20 |
2007-01-04 |
Ash Access Technology, Inc. |
Anti-clotting indwelling catheter
|
WO2007001049A1
(en)
|
2005-06-29 |
2007-01-04 |
Kyowa Hakko Kogyo Co., Ltd. |
Benzenoid ansamycin derivative
|
DE102005037733A1
(en)
|
2005-08-10 |
2007-02-15 |
Merck Patent Gmbh |
adenine
|
WO2007022042A2
(en)
|
2005-08-11 |
2007-02-22 |
Novartis Ag |
Combinations comrising a protein kinase inhibitor being a pyrimidylaminobξnzamide compound and a hsp90 inhibitor such as 17-aag
|
CA2618724A1
(en)
|
2005-08-18 |
2007-02-22 |
Synta Pharmaceuticals Corp. |
Imidazole compounds that modulate hsp90 activity
|
GB0519245D0
(en)
|
2005-09-20 |
2005-10-26 |
Vernalis R&D Ltd |
Purine compounds
|
JO2783B1
(en)
|
2005-09-30 |
2014-03-15 |
نوفارتيس ايه جي |
2-Amino-7,8-Dihidro-6H-Pyrido(4,3-D)Pyrimidin-5-ones
|
US7745893B2
(en)
|
2005-10-17 |
2010-06-29 |
Northern Lights Semiconductor Corp. |
Magnetic transistor structure
|
US20070105862A1
(en)
|
2005-11-10 |
2007-05-10 |
Milan Bruncko |
Heat-shock protein binders
|
CN101360492A
(en)
|
2005-12-01 |
2009-02-04 |
康福玛医药公司 |
Compositions containing ansamycin
|
US20090209494A1
(en)
|
2005-12-24 |
2009-08-20 |
Christine Janet Martin |
21-deoxymacbecin analogues useful as antitumor agents
|
EP2012791A4
(en)
|
2006-02-07 |
2010-09-22 |
Conforma Therapeutics Corp |
7,9-dihydro-purin-8-one and related analogs as hsp90-inhibitors
|
US20070207992A1
(en)
|
2006-02-21 |
2007-09-06 |
Board Of Trustees Of Michigan State University |
Geldanamycin derivatives and method of use thereof
|
ATE531718T1
(en)
|
2006-03-11 |
2011-11-15 |
Vernalis R&D Ltd |
PYRROLOPYRIMIDE DERIVATIVES USED AS HSP90 INHIBITORS
|
WO2007117466A2
(en)
|
2006-03-31 |
2007-10-18 |
Massachusetts Institute Of Technology |
Celastrol, gedunin, and derivatives thereof as hsp90 inhibitors
|
MX2008013582A
(en)
|
2006-04-26 |
2009-01-19 |
Hoffmann La Roche |
Pyrimidine derivatives as pi3k inhibitors.
|
EP2026805A1
(en)
|
2006-05-08 |
2009-02-25 |
Astex Therapeutics Limited |
Pharmaceutical combinations of diazole derivatives for cancer treatment
|
EP1928837A2
(en)
|
2006-05-09 |
2008-06-11 |
Biotica Technology Limited |
18,21-didesoxymacbecin derivatives for the treatment of cancer
|
GB0609117D0
(en)
|
2006-05-09 |
2006-06-21 |
Biotica Tech Ltd |
Novel compounds
|
CN101490052B
(en)
|
2006-05-12 |
2012-08-08 |
美瑞德生物工程公司 |
Therapeutic compounds and their use in cancer
|
DE102006023336A1
(en)
|
2006-05-18 |
2007-11-22 |
Merck Patent Gmbh |
1,5-diphenyl-pyrazoles II
|
DE102006023337A1
(en)
|
2006-05-18 |
2007-11-22 |
Merck Patent Gmbh |
Triazole derivatives II
|
US20080125587A1
(en)
|
2006-05-25 |
2008-05-29 |
Chimmanamada Dinesh U |
Synthesis of triazole compounds that modulate HSP90 activity
|
AU2007267852A1
(en)
|
2006-05-25 |
2007-12-06 |
Synta Pharmaceuticals Corp. |
Compounds that modulate Hsp90 activity and methods for identifying same
|
AU2007267847B2
(en)
|
2006-05-25 |
2012-04-12 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate Hsp90 activity
|
JP5410965B2
(en)
|
2006-05-25 |
2014-02-05 |
シンタ ファーマシューティカルズ コーポレーション |
Triazole compounds that modulate Hsp90 activity
|
EP2034995A2
(en)
|
2006-05-25 |
2009-03-18 |
Synta Pharmaceuticals Corporation |
Method for treating proliferative disorders associated with protooncogene products
|
SI2035396T1
(en)
|
2006-05-25 |
2014-08-29 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate hsp90 activity
|
AR061185A1
(en)
|
2006-05-26 |
2008-08-13 |
Chugai Pharmaceutical Co Ltd |
HETEROCICLICAL COMPOUNDS AS INHIBITORS OF HSP90. PHARMACEUTICAL COMPOSITIONS.
|
KR20090015118A
(en)
|
2006-05-26 |
2009-02-11 |
레가도 바이오사이언스, 인코포레이티드 |
Administration of the reg1 anticoagulation system
|
WO2008150302A1
(en)
|
2007-06-04 |
2008-12-11 |
Nexgenix Pharmaceuticals |
Treatment of neurofibromatosis with radicicol and its derivatives
|
DE102006030479A1
(en)
|
2006-07-01 |
2008-03-20 |
Merck Patent Gmbh |
indazole
|
CA2696021C
(en)
|
2006-08-11 |
2015-09-29 |
Nicolas Winssinger |
Macrocyclic compounds useful as inhibitors of kinases and hsp90
|
JP2010500396A
(en)
|
2006-08-16 |
2010-01-07 |
4エスツェー アクチェンゲゼルシャフト |
Tetrahydrobenzothiophene derivatives
|
CA2660794A1
(en)
|
2006-08-16 |
2008-02-21 |
4Sc Ag |
Ntetrahydropyridothiophene derivatives for the treatment of cancer
|
CA2659425C
(en)
|
2006-08-17 |
2017-06-20 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate hsp90 activity
|
US7678803B2
(en)
|
2006-08-24 |
2010-03-16 |
Serenex, Inc. |
Quinazoline derivatives for the treatment of cancer
|
US20090093452A1
(en)
|
2006-08-24 |
2009-04-09 |
Pfizer Inc. |
Pyrrole, Thiophene, Furan, Imidazole, Oxazole, and Thiazole Derivatives
|
WO2008024981A1
(en)
|
2006-08-24 |
2008-02-28 |
Serenex, Inc. |
Piperazine-substituted benzothiophenes for treatment of mental disorders
|
US20080119457A1
(en)
|
2006-08-24 |
2008-05-22 |
Serenex, Inc. |
Benzene, Pyridine, and Pyridazine Derivatives
|
WO2008024974A1
(en)
|
2006-08-24 |
2008-02-28 |
Serenex, Inc. |
Pyrimidine and pyrazine derivatives
|
WO2008024961A1
(en)
|
2006-08-24 |
2008-02-28 |
Serenex, Inc. |
Dihydropyridazine, tetrahydropyridine, chromanone, and dihydronaphthalenone derivatives as heat-shock protein 90 inhibitors
|
SI2065388T1
(en)
|
2006-09-19 |
2012-03-30 |
Daiichi Sankyo Co Ltd |
Pyrazolopyrimidine derivative
|
GB0620259D0
(en)
|
2006-10-12 |
2006-11-22 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
US20110046125A1
(en)
|
2006-10-19 |
2011-02-24 |
Synta Pharmaceuticals Corp. |
Method for treating infections
|
CL2007002994A1
(en)
|
2006-10-19 |
2008-02-08 |
Wyeth Corp |
HETEROCICLIC DERIVATIVE COMPOUNDS CONTAINING SULFAMOIL, INHIBITORS OF HSP90; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF CANCER, SUCH AS CANCER OF BREAST, COLON AND PROSTATE, BETWEEN OTHERS.
|
FR2907453B1
(en)
|
2006-10-24 |
2008-12-26 |
Sanofi Aventis Sa |
NOVEL FLUORENE DERIVATIVES, COMPOSITIONS CONTAINING SAME AND USE THEREOF
|
WO2008057246A2
(en)
|
2006-10-26 |
2008-05-15 |
Synta Pharmaceuticals Corp. |
Method for treating inflammatory disorders
|
WO2008053319A1
(en)
|
2006-10-30 |
2008-05-08 |
Pfizer Products Inc. |
Amide resorcinol compounds
|
GB0622084D0
(en)
|
2006-11-06 |
2006-12-13 |
Chroma Therapeutics Ltd |
Inhibitors of HSP90
|
WO2008059368A2
(en)
|
2006-11-17 |
2008-05-22 |
Pfizer Products Inc. |
Fused 2-amino pyrimidine compounds and their use for the treatment of cancer
|
PE20081506A1
(en)
|
2006-12-12 |
2008-12-09 |
Infinity Discovery Inc |
ANSAMYCIN FORMULATIONS
|
KR100872664B1
(en)
|
2006-12-15 |
2008-12-10 |
현대자동차주식회사 |
Air conditioner compressor having friction member in cylinder
|
DE102007002715A1
(en)
|
2007-01-18 |
2008-07-24 |
Merck Patent Gmbh |
triazole
|
CN101652365A
(en)
|
2007-02-01 |
2010-02-17 |
阿斯利康(瑞典)有限公司 |
5,6,7,8-tetrahydropteridine derivatives as HSP90 inhibitors
|
CA2677365A1
(en)
|
2007-02-06 |
2008-08-14 |
Pfizer Inc. |
2-amino-5, 7-dihydro-6h-pyrrolo [3, 4-d] pyrimidine derivatives as hsp- 90 inhibitors for treating cancer
|
DK2118077T3
(en)
|
2007-02-08 |
2015-03-09 |
Synta Pharmaceuticals Corp |
Triazole compounds that modulate HSP90 ACTIVITY
|
TW200904417A
(en)
|
2007-02-20 |
2009-02-01 |
Synta Pharmaceuticals Corp |
Triazole compounds that modulate Hsp90 activity
|
EP2119718B1
(en)
|
2007-03-01 |
2012-04-11 |
Chugai Seiyaku Kabushiki Kaisha |
Macrocyclic compound
|
WO2008110508A1
(en)
*
|
2007-03-09 |
2008-09-18 |
Glaxo Group Limited |
Pyrrolo-pyridine derivatives for the treatment of disorders associated with inappropriate ikk1 activity
|
US8993608B2
(en)
|
2007-03-12 |
2015-03-31 |
Synta Pharmaceuticals Corp. |
Method for inhibiting topoisomerase II
|
BRPI0808301B1
(en)
|
2007-03-20 |
2022-05-03 |
Curis, Inc |
Compound and pharmaceutical composition
|
WO2008115262A2
(en)
|
2007-03-20 |
2008-09-25 |
Curis, Inc. |
Hsp90 inhibitors containing a zinc binding moiety
|
AU2008232354B9
(en)
|
2007-03-27 |
2012-07-26 |
Synta Pharmaceuticals Corp. |
Triazinone and diazinone derivatives useful as Hsp90 inhibitors
|
CA2684240A1
(en)
|
2007-04-16 |
2008-10-30 |
Serenex, Inc. |
Tetrahydroindole and tetrahydroindazole derivatives
|
GB2449293A
(en)
|
2007-05-17 |
2008-11-19 |
Evotec |
Compounds having Hsp90 inhibitory activity
|
FR2916443B1
(en)
|
2007-05-24 |
2012-08-03 |
Sanofi Aventis |
NOVEL ANALOGUE DERIVATIVES OF HERBIMYCIN A, COMPOSITIONS CONTAINING SAME AND USE THEREOF.
|
DE102007028521A1
(en)
|
2007-06-21 |
2008-12-24 |
Merck Patent Gmbh |
Indazolamidderivate
|
WO2009007399A1
(en)
|
2007-07-12 |
2009-01-15 |
Crystax Pharmaceuticals, S.L. |
New compounds as hsp90 inhibitors
|
DE102007032739A1
(en)
|
2007-07-13 |
2009-01-15 |
Merck Patent Gmbh |
Chinazolinamidderivate
|